Globus Medical, Inc.

US$71.05As of Sun 8 Nov 2026, 12:00 UTC
NYSE:GMEDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 12.35%
Div yield —
ROE 12.13%
Medical Devices
Beta (5Y) 0.95
PE TTM 17.50
TSR TTM 17.65%
Mkt cap US$9.412B
ROIC 13.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$69
(3.31%)
(70.57%)
Buy 9|5|3|3|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.03
1.02
1.07
1.09
27.18%
26.86%
20.97%
14.10%
Revenue$M
453.4
450.7
448.0
463.1
11.82%
6.69%
5.72%
5.12%
Peers (US$9.412B)
Cap (US$)
PE
10.16B
23.90x
9.363B
—
7.903B
32.38x
Capital
TTM
5Y
10Y
Leveragex
2.377
(1.895)
(1.341)
EBIT/Intx
0.349
0.306
0.294
Own earn%
5.85
112.50
103.42
Sh yield%
28.50
14.16
17.05
Owners
Insiders/Inst%
7.80
28.64
Short interest%
3.65
SBC / revenue%
1.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
15–25
$1 testx
0.0
Incr. ROIC%
13